Sarah Schick is an Associate on DLA Piper's Food and Drug Administration team. She focuses her practice on regulatory matters impacting the life sciences and healthcare industries. Sarah's practice centers on providing clients with strategic counsel on regulatory matters intersecting with litigation or corporate decision making. She has extensive experience advising clients developing and marketing medical products on clinical development strategy, Good Clinical Practice and Good Manufacturing Practice issues, clinical trial and commercial contractual matters, compliance programming and risk management. In 2021, Sarah was also seconded on a part-time basis to a large global pharmaceutical company. Before joining DLA Piper, Sarah served as in-house counsel for a publicly traded biopharmaceutical company and also gained experience working in the legal department for a large hospital system in Texas. Prior to her legal career, she was involved in clinical trial project management, health outcomes research and healthcare diplomacy. Sarah has also been the recent recipient of awards and recognitions, including being named to the National Black Lawyer’s 40 Under 40 list in Texas, and selected to the 2021 Leadership Council on Leadership Diversity (LCLD) Pathfinder Program. Sarah has a B.S. in Public Administration and M.S. in Health Systems Management from George Mason University and a J.D. from the University of Virginia School of Law.